Reporting Manager
Invus Public Equities, L.P.
Symbol
ABVX
Shares outstanding
63,576,294 shares
Disclosed Ownership
5,403,985 shares
Ownership
8.5%
Form type
SCHEDULE 13G
Filing time
11 Apr 2025, 16:43:54 UTC
Date of event
02 Sep 2022
Next filing
13 Feb 2026

Sponsored

Quoteable Key Fact

"Invus Global Management, LLC disclosed 8.5% ownership in Abivax S.A. Ordinary shares, nominal value Euro 0.01 per share (ABVX) on 02 Sep 2022."

Quick Takeaways

  • Invus Global Management, LLC filed SCHEDULE 13G for Abivax S.A. Ordinary shares, nominal value Euro 0.01 per share (ABVX).
  • Disclosed ownership: 8.5%.
  • Date of event: 02 Sep 2022.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 11 Apr 2025, 16:43.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Invus Public Equities, L.P. 8.5% 5,403,985 5,403,985 0 /s/ Raymond Debbane Raymond Debbane, President, Invus Public Equities Advisors, LLC, its general partner
Invus Public Equities Advisors, LLC 8.5% 5,403,985 5,403,985 0 /s/ Raymond Debbane Raymond Debbane, President
Invus Global Management, LLC 8.5% 5,403,985 5,403,985 0 /s/ Raymond Debbane Raymond Debbane, President
Siren, L.L.C. 8.5% 5,403,985 5,403,985 0 /s/ Raymond Debbane Raymond Debbane, President
Raymond Debbane 8.5% 5,403,985 5,403,985 0 /s/ Raymond Debbane Raymond Debbane